D
Acronyms


ANOVA

analysis of variance


CDER

Center for Drug Evaluation and Research (FDA)

CNS

central nervous system

CPMP

Committee on Proprietary Medicinal Products (European Union)

CSM

Committee on the Safety of Medicines (United Kingdom)


EEG

electroencephalogram

EMIC

Evaluation of Medications for Insomnia in Canada


FDA

U.S. Food and Drug Administration


IOM

Institute of Medicine

ISS

Integrated Summary of Safety


MCA

Medicines Control Agency (United Kingdom)

MHPG

methoxyhydroxyphenylglycol


NDA

New Drug Application

NDTI

National Disease and Therapeutic Index

NPA

National Prescription Audit


PAAC

Psychopharmacologic Agents Advisory Committee

PDAC

Psychopharmacologic Drugs Advisory Committee

PLMS

periodic limb movements of sleep


REM

rapid eye movement


SPECT

single photon emission computerized tomography

SRS

Spontaneous Reporting System


VAMP

Value Added Medicinal Products Research



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 145
Halcion: An Independent Assessment of Safety and Efficacy Data D Acronyms ANOVA analysis of variance CDER Center for Drug Evaluation and Research (FDA) CNS central nervous system CPMP Committee on Proprietary Medicinal Products (European Union) CSM Committee on the Safety of Medicines (United Kingdom) EEG electroencephalogram EMIC Evaluation of Medications for Insomnia in Canada FDA U.S. Food and Drug Administration IOM Institute of Medicine ISS Integrated Summary of Safety MCA Medicines Control Agency (United Kingdom) MHPG methoxyhydroxyphenylglycol NDA New Drug Application NDTI National Disease and Therapeutic Index NPA National Prescription Audit PAAC Psychopharmacologic Agents Advisory Committee PDAC Psychopharmacologic Drugs Advisory Committee PLMS periodic limb movements of sleep REM rapid eye movement SPECT single photon emission computerized tomography SRS Spontaneous Reporting System VAMP Value Added Medicinal Products Research